Fall in haemoglobin levels(g/L or mmol/L) ( · people with PAD undergoing MLLA
1 finding from 1 review
Blood transfusion · people with PAD undergoing MLLA
1 finding from 1 review
Primary wound‐healing rates (6 weeks) · people with PAD undergoing MLLA
1 finding from 1 review
Stump revision rates (maximal · people with PAD undergoing MLLA
1 finding from 1 review
Postoperative complications (maximal · people with PAD undergoing MLLA
1 finding from 1 review
Postoperative mortality (6 weeks) · people with PAD undergoing MLLA
1 finding from 1 review
All‐cause mortality ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes all‐cause mortality ( compared with control (very low certainty).
1 finding from 1 review
Reduction in pain Various scales including VAS, PISQ; scales ranged from 0 to 4/10/100, where 0 = no pain ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Amputation · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes incidence of amputation ( compared with control (very low certainty).
1 finding from 1 review
Angiographic analysis · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Increase in ABI An ABI ratio of 0.9 or less indicates PAD. Values between 0.9 and 1.0 are borderline, and above 1.0 is considered normal ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Increase in PFWD (m) ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Complications and side effects · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes side effects and complications ( compared with control (very low certainty).
1 finding from 1 review
Intervention not reported
Complete clot lysis (intermediate, 6 months to under 5 years after treatment) · patients diagnosed with acute DVT
The intervention probably leads to higher complete clot lysis (intermediate, 6 months to under 5 years after… (moderate certainty).
1 finding from 1 review
Intervention not reported
Bleeding (early, up to 1 month after treatment) · patients diagnosed with acute DVT
The intervention probably leads to higher bleeding (early, up to 1 month after treatment) (moderate certainty).
1 finding from 1 review
Intervention not reported
Post‐thrombotic syndrome (intermediate, 6 months to under 5 years after treatment) · patients diagnosed with acute DVT
The intervention probably leads to lower post‐thrombotic syndrome (intermediate, 6 months to under 5 years… (moderate certainty).
1 finding from 1 review
Intervention not reported
Post‐thrombotic syndrome (late, 5 years · patients diagnosed with acute DVT
The intervention probably leads to lower post‐thrombotic syndrome (late, 5 years (moderate certainty).
1 finding from 1 review
Intervention not reported
Early postoperative non‐thrombotic complications · Individuals with peripheral arterial disease
The intervention showed no clear difference in early postoperative non‐thrombotic complications (high certainty).
1 finding from 1 review
Intervention not reported
Procedural mortality · Individuals with peripheral arterial disease
The intervention showed no clear difference in procedural mortality (high certainty).
1 finding from 1 review
Intervention not reported
Clinical improvement · Individuals with peripheral arterial disease
The intervention showed no clear difference in clinical improvement (low certainty).
1 finding from 1 review